Shiseido, which has built a cell processing center in Kobe in May 2014, has obtained permission to initiate own and clinical studies based on Canada’s RepliCel hair regrowth technology (RCH-01). Using this technology, cells are collected from the back of the head, reprogrammed and transplanted.

Nikkei Biotech news release, Sept. 30, 2015